overlay landing page

We have 911 Active VC firms investing in Diagnostics on Angels Partners

main investor picture
TELUS Ventures
Investing in IT (& TMT) • Media • AgroT...
 British Columbia Vanc..., Canada
  • main investor picture
    Jay Crone
    Principal
  • main investor picture
    Karan Mavai
    Investment Director
  • main investor picture
    Rob Peets
    Investment Director
  • main investor picture
    Jon Wolkin
    Investment Director
  • main investor picture
    Richard Osborn
    Managing Partner
Investor Picture
Previous Investments
  • • AgriWebb: $22990000 (Later stage VC)
  • • MindBeacon Group: $18000000 (Later stage VC)
  • • Vox Mobile: $6700000 (Later stage VC)
  • • Zenedge: $6200000 (Later stage VC)
  • • PatientSafe Solutions: $4500000 (Other)
  • • Sprout: $500000 (Other)
  • • DOmedic: (Later stage VC)
  • • Sentrian: (Early stage VC)
  • • Heart and Stroke SIB: (Later stage VC)
  • • Alithya: (Later stage VC)
  • • Beacon (Therapy):

TELUS Ventures

British Columbia Vancouver, Canada, Canada

Contact this investors  
Investing In

IT (& TMT) • Media • AgroTech • Businesses Solutions • FinTech (& Financials services) • HealthTech (& Fitness) • Web Security (& Privacy) • Food & Beverage • Medical Devices (& Hospital Services) • Payments • SaaS • Healthcare (& Wellness) • Investment Management • Life Science • Mobile • Consumer • Pharmaceutical (& Medicine) • Diagnostics

Description

TELUS Ventures is the venture capital arm of TELUS, a North American telecommunications company headquartered in Vancouver, Canada. The firm partners with privately held companies that offer unique technologies and innovative products that will accelerate growth initiatives within TELUS. The firm actively seeks synergistic investments in digital health, internet of things, big data, artificial intelligence, machine learning, security, managed information technology services, wireless, and next-generation network infrastructure.

main investor picture
Primary Venture Partners
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Califor..., United States
  • main investor picture
    Steve Schlafman
    Angel
  • main investor picture
    Benjamin Sun
    General Partner
  • main investor picture
    Brad Svrluga
    General Partner
  • main investor picture
    Bob Peruzzi
    Chief Financial Officer
  • main investor picture
    Jason Shuman
    Partner
  • main investor picture
    Brian Schechter
    Partner
  • main investor picture
    Cassie Young
    General Partner
  • main investor picture
    Sam Toole
    Principal
  • main investor picture
    Tobias Citron
    Senior Associate
  • main investor picture
    Bradley Svrluga
    Partner
  • main investor picture
    Alex Gannon
    Partner
Investor Picture
Previous Investments
  • • Hammerhead: $4200000 (Seed Round)
  • • Retreat Guru: $1000000 (Seed Round)
  • • Citizen: $12000000 (Series A)
  • • Care/of: $10200000 (Series A)
  • • Poncho: $2000000 (Seed Round)
  • • The Black Tux: $2600000 (Seed Round)
  • • K Health: $132000000 (Later stage VC)
  • • Project 1972: $3010000 (Early stage VC)
  • • Helaina: $45000000 (Series B)
  • • Helaina: $20000000 (Series A)
  • • Helaina: $4000000 (Seed)
  • • Naya Homes: $3000000 (Seed)
  • • Naya Homes: $5000000 (Seed)
  • • Marker Learning: $15000000 (Series A)
  • • Marker Learning: $4000000 (Seed)
  • • Retirable: $6000000 (Seed)
  • • Realm: $12000000 (Series A)
  • • Realm: $3000000 (Seed)
  • • Lili: $15000000 (Series A)
  • • Reframe Technologies: $5000000 (Seed)
  • • Duro: $8000000 (Seed)
  • • Lunchbox Technologies: $50000000 (Series B)
  • • Lunchbox Technologies: $20000000 (Series A)
  • • Lunchbox Technologies: $2000000 (Seed)
  • • Electric: $90000000 (Series D)
  • • Electric: $40000000 (Series C)
  • • Electric: $9000000 (Series A)
  • • Electric: $1000000 (Series Unknown)
  • • Electric: $2000000 (Seed)
  • • Stellar Health: $60000000 (Series B)
  • • Stellar Health: $10000000 (Series A)
  • • Stellar Health: $5000000 (Seed)
  • • Odeko: $70000000 (Series B)
  • • Odeko: $12000000 (Series A)
  • • Odeko: $8000000 (Seed)
  • • Odeko: $6000000 (Pre Seed)
  • • Virtual Facility: (Seed)
  • • Alloy: $40000000 (Series B)
  • • Alloy: $12000000 (Series A)
  • • Alloy: $4000000 (Seed)
  • • OneThree Biotech: $3000000 (Seed)
  • • Reonomy: $60000000 (Series D)
  • • Reonomy: $16000000 (Series Unknown)
  • • Reonomy: $13000000 (Series B)
  • • Reonomy: $4000000 (Series A)
  • • Reonomy: $1000000 (Seed)
  • • Kinetic: $5000000 (Seed)
  • • Healthify: $3000000 (Seed)
  • • Routehappy: $3000000 (Series A)
  • • Routehappy: $2000000 (Seed)
  • • Fieldlens: $8000000 (Series A)
  • • Fieldlens: $2000000 (Seed)
  • • Strut Learning: $15000000 (Series B)
  • • Strut Learning: $8000000 (Series A)
  • • Savored: $3000000 (Series A)
  • • Divide: $2000000 (Seed)
  • • Pump Audio: (Series Unknown)
  • • Pump Audio: $3000000 (Series A)
  • • Allworx: $4000000 (Series A)
  • • Lantern: $1000000 (Seed)
  • • Lyric: $4000000 (Seed)
  • • Spark Advisors: $3600000 (Seed Round)
  • • Small Door: $40000000 (Series B)
  • • Small Door: $20000000 (Series A)
  • • CozyKin: $6000000 (Series A)
  • • Kindred: $3000000 (Seed)
  • • SimpleReach: $14000000 (Series B)
  • • SimpleReach: $9000000 (Series A)
  • • SimpleReach: $2000000 (Seed)
  • • Coupang: $100000000 (Venture Round)
  • • Coupang: $100000000 (Series Unknown)
  • • Fashion Project: $2000000 (Seed)
  • • HumanX: $6000000 (Seed)
  • • Etched.ai: $5000000 (Seed)

Primary Venture Partners

San Francisco California - San Francisco Bay Area - SF Bay Area New York - New York City, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • PropTech • Education • AgroTech • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • Sales (& Marketing) • Cosmetics (& Fashion) • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Analytics • AR/VR • Developer tools • Food & Beverage • Impact • Medical Devices (& Hospital Services) • Payments • Real Estate (& Construction) • SaaS • Healthcare (& Wellness) • Investment Management • LegalTech • Life Science • Mobile • Mobility • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics

Description

Primary Venture Partners is an early stage venture capital firm which makes seed investments in industry-transforming technology companies and reserve capital to follow initial investments across multiple financings. The firm focuses on investing in companies within the business products, business services, mobile, software, information technology, enterprise SaaS, nextgen commerce, manufacturing and energy sectors.

main investor picture
StartUp Health
Investing in HealthTech (& Fitness) • Advert...
 San Francisco Bay Are..., United States
  • main investor picture
    Unity Stoakes
    President
  • main investor picture
    Steven Krein
    Managing Partner
Investor Picture
Previous Investments
  • • Conversa: $20000000 (Later stage VC)
  • • Eko.ai: $4000000 (Early stage VC)
  • • Sift Medical Data: $630000 (Seed Round)
  • • WellBrain: $50000 (Seed Round)
  • • Elly:
  • • doc-doc: $500000 (Pre Seed)
  • • Diagnostikare: (Seed)

StartUp Health

San Francisco Bay Area - San Diego California - New York City, United States

Contact this investors  
Investing In

HealthTech (& Fitness) • Advertising • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Consumer • Pharmaceutical (& Medicine) • Diagnostics

Description

Founded in 2011, StartUp Health is a venture capital firm based in New York, New York. The firm invests in healthcare and healthcare technology sector.

main investor picture
Mayfield Fund
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Bay Are..., United States
  • main investor picture
    Paul Kohli
    Vice President of Investment Operations
  • main investor picture
    Vaneeta Varma
    CFO
  • main investor picture
    Yogen Dalal
    Co-Founder
  • main investor picture
    Vikram Godse
    Managing Partner
Investor Picture
Previous Investments
  • • Poshmark: $87500000 (Later stage VC)
  • • Vexata: $54000000 (Later stage VC)
  • • HashiCorp: $40000000 (Later stage VC)
  • • InfluxData: $35000000 (Later stage VC)
  • • Grove Collaborative: $35000000 (Later stage VC)
  • • Stockpile: $30000000 (Later stage VC)
  • • BigPanda: $23000000 (Later stage VC)
  • • Zipongo: $18000000 (Later stage VC)
  • • Arcadia Data: $15000000 (Later stage VC)
  • • Berbix: $11570000 (Later stage VC)
  • • Mission Bio: $10000000 (Early stage VC)
  • • ShiftLeft: $9300000 (Early stage VC)
  • • TrustRadius: $5500000 (Later stage VC)
  • • M1xchange: $4500000 (Early stage VC)
  • • TRIPP: $4000000 (Early stage VC)
  • • Phiar Technologies: $3000000 (Seed Round)

Mayfield Fund

San Francisco Bay Area (CA) - Menlo Park, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Entertainment (& Sports) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • Human Resources • Impact • Material Science • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • SaaS • FoodTech • Healthcare (& Wellness) • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Online Social • Consumer • Pharmaceutical (& Medicine) • Restaurants • Woman Focused • Diagnostics • Productivity

Description

Mayfield Fund is a venture capital firm which specializes in seed, early stage, later stage and growth investments. It invests in companies based in the United States, Europe, India and China operating in the agribusiness, financial services, energy, data, communication, infrastructure, software, internet of things, clean energy, retail, business e-commerce and healthcare sectors. The firm was founded in 1969 and is based in Menlo Park, California.

main investor picture
Polaris Partners
Investing in Software (Web Marketplace Saas..) &b...
 Boston Massachusetts, United States
  • main investor picture
    Peter Flint
    Partner
  • main investor picture
    Gary Swart
    General Partner
  • main investor picture
    Bryce Youngren
    Managing Partner
  • main investor picture
    Jon Flint
    Partner
  • main investor picture
    John Gannon
    General Partner
  • main investor picture
    Alan Crane
    Partner
  • main investor picture
    Paulina Hill
    Partner
  • main investor picture
    Brian Chee
    Managing Partner
  • main investor picture
    Amir Nashat
    Managing Partner
  • main investor picture
    Terry McGuire
    Partner
  • main investor picture
    Dave Barrett
    Managing Partner
  • main investor picture
    David Barrett
    Partner
  • main investor picture
    Dan Lombard
    Partner
  • main investor picture
    Sabrina Chiasson
    Principal
  • main investor picture
    Alexandra Cantley
    Partner
  • main investor picture
    Darren Carroll
    Managing Partner
  • main investor picture
    Ellie McGuire
    Partner
  • main investor picture
    Sharif Vakili
    Associate
  • main investor picture
    Marissa Bertorelli
    Principal
  • main investor picture
    Jay Boland
    Investor
  • main investor picture
    Mark Jacobson
    Vice President
  • main investor picture
    Pat Mulach
    Associate
  • main investor picture
    Maureen St. Pierre
    Analyst
  • main investor picture
    Harold Friedman
    Partner
  • main investor picture
    Brendan Hannigan
    Partner
  • main investor picture
    Darren JD
    Partner
  • main investor picture
    Jeff Presto
    Partner
Investor Picture
Previous Investments
  • • Visterra: $23600000 (Series C)
  • • Akero Therapeutics: $65000000 (Series A)
  • • Neuronetics: $15000000 (Series G)
  • • Neuronetics: $34300000 (Series F)
  • • Neuronetics: $30000000 (Series E)
  • • Visterra: $23100000 (Series C)
  • • Visterra: $30000000 (Series B)
  • • Visterra: $8100000 (Series A)
  • • Visterra: $26100000 (Series A)
  • • Visterra: $3300000 (Seed Round)
  • • Kala Pharmaceuticals: $68000000 (Series C)
  • • Kala Pharmaceuticals: $22500000 (Series B)
  • • Kala Pharmaceuticals: $11500000 (Series A)
  • • Kala Pharmaceuticals: $7200000 (Private Equity Round)
  • • Genocea Biosciences: $30000000 (Series C)
  • • Genocea Biosciences: $35000000 (Series B)
  • • Genocea Biosciences: (Series B)
  • • Vets First Choice: $4000000 (Venture Round)
  • • Follica: $135000 (Series B)
  • • Follica: $7500000 (Series B)
  • • Follica: $11000000 (Series B)
  • • Biolex Therapeutics: $30000000 (Series C)
  • • Biolex Therapeutics: $36000000 (Series B)
  • • Seventh Sense Biosystems: $10000000 (Series C)
  • • Seventh Sense Biosystems: $16000000 (Series B)
  • • Seventh Sense Biosystems: $10000000 (Series A)
  • • Seventh Sense Biosystems: $4500000 (Series A)
  • • Quartet: $45000000 (Later stage VC)
  • • Lyra Therapeutics: $29500000 (Later stage VC)
  • • TARIS Biomedical: $25000000 (Later stage VC)
  • • Baxter Planning Systems: $25000000 (Other)
  • • Metacrine: $22000000 (Later stage VC)
  • • ClearSky Data: $20000000 (Later stage VC)
  • • Suono Bio: (Seed Round)
  • • TransACT Communications: (Private Equity Round)
  • • LastPass: $10000000 (Series B)
  • • Pulmatrix: $10000000 (Post Ipo Equity)
  • • Pulmatrix: $14000000 (Series B)
  • • Pulmatrix: $30000000 (Series B)
  • • Pulmatrix: $4000000 (Series A)
  • • UpDoc: (Seed)
  • • SpineZone: $12000000 (Series A)
  • • Livara Health: $15000000 (Series B)
  • • Livara Health: $12000000 (Series A)
  • • FloQast: $110000000 (Series D)
  • • FloQast: $40000000 (Series C)
  • • FloQast: $25000000 (Series B)
  • • FloQast: $7000000 (Series A)
  • • Preply: $35000000 (Series B)
  • • Preply: $10000000 (Series A)
  • • Stensul: $16000000 (Series B)
  • • Cobalt: $29000000 (Series B)
  • • Swiftly: $3000000 (Seed)
  • • Qstream: $15000000 (Series B)
  • • B12: $12000000 (Series A)
  • • Envoy: $3000000 (Seed)
  • • CliQr Technologies: $20000000 (Series C)
  • • Tome Biosciences: $210000000 (Series A)
  • • Seismic Therapeutic: $120000000 (Series B)
  • • Seismic Therapeutic: $100000000 (Series A)
  • • Dyno Therapeutics: $100000000 (Series A)
  • • Dyno Therapeutics: $9000000 (Seed)
  • • Pandion Therapeutics: $58000000 (Series A)
  • • YourBio Health: $10000000 (Series C)
  • • YourBio Health: $16000000 (Series B)
  • • YourBio Health: $10000000 (Series A)
  • • YourBio Health: $5000000 (Series A)
  • • Navitor Pharmaceuticals: $33000000 (Series B)
  • • Navitor Pharmaceuticals: $24000000 (Series A)
  • • T2 Biosystems: $40000000 (Series E)
  • • T2 Biosystems: $23000000 (Series D)
  • • T2 Biosystems: $15000000 (Series C)
  • • T2 Biosystems: $11000000 (Series B)
  • • T2 Biosystems: $6000000 (Series A)
  • • Cerulean Pharma: $13000000 (Private Equity)
  • • Cerulean Pharma: $15000000 (Series D)
  • • Cerulean Pharma: $24000000 (Series C)
  • • Cerulean Pharma: $10000000 (Series B)
  • • Cerulean Pharma: $8000000 (Series B)
  • • Cerulean Pharma: $12000000 (Series A)
  • • Cerulean Pharma: $2000000 (Series Unknown)
  • • Ocular Therapeutix: $14000000 (Series D)
  • • Ocular Therapeutix: $6000000 (Series C)
  • • Ocular Therapeutix: $15000000 (Series C)
  • • Hydra Biosciences: $22000000 (Series D)
  • • Hydra Biosciences: $34000000 (Series C)
  • • Hydra Biosciences: $19000000 (Series B)
  • • Hydra Biosciences: $9000000 (Series A)
  • • Adnexus: $16000000 (Series C)
  • • Adnexus: $27000000 (Series B)
  • • Adnexus: $13000000 (Series A)
  • • Noetik: $40000000 (Series A)
  • • ByHeart: $95000000 (Series C)
  • • ByHeart: $70000000 (Series A)
  • • Vico Therapeutics: $72000000 (Series B)
  • • Vico Therapeutics: $31000000 (Series A)
  • • Engine Biosciences: $27000000 (Series A)
  • • Engine Biosciences: $43000000 (Series A)
  • • Larkspur Biosciences: $36000000 (Series A)
  • • Volastra Therapeutics: $60000000 (Series A)
  • • Volastra Therapeutics: $32000000 (Seed)
  • • Volastra Therapeutics: $12000000 (Seed)
  • • Thirty Madison: $140000000 (Series C)
  • • Thirty Madison: $47000000 (Series B)
  • • Keeps: $47000000 (Series B)
  • • Glympse Bio: $47000000 (Series B)
  • • Glympse Bio: $22000000 (Series A)
  • • SQZ Biotech: $65000000 (Series D)
  • • SQZ Biotech: (Series D)
  • • SQZ Biotech: $72000000 (Series C)
  • • SQZ Biotech: $16000000 (Series B)
  • • SQZ Biotech: $5000000 (Series A)
  • • QurAlis: $42000000 (Series A)
  • • Cardurion Pharmaceuticals: (Series A)
  • • Quentis Therapeutics: $48000000 (Series A)
  • • Cohere Health: $50000000 (Series C)
  • • Cohere Health: $36000000 (Series B)
  • • Tausight: $6000000 (Series Unknown)
  • • Tausight: $20000000 (Series A)
  • • Simon Data: $54000000 (Series D)
  • • Simon Data: $30000000 (Series C)
  • • Simon Data: $20000000 (Series B)
  • • Sonrai Security: $50000000 (Series C)
  • • Sonrai Security: $20000000 (Series B)
  • • Sonrai Security: $19000000 (Series A)
  • • OM1: $85000000 (Series D)
  • • OM1: $50000000 (Series C)
  • • OM1: $21000000 (Series B)
  • • Armorblox: $30000000 (Series B)
  • • Recurly: $20000000 (Series C)
  • • Recurly: $12000000 (Series B)
  • • Recurly: $6000000 (Series A)
  • • Recurly: $2000000 (Seed)
  • • Lob: $23000000 (Series B)
  • • Lob: $7000000 (Series A)
  • • Lob: $2000000 (Seed)
  • • InsideSales: $50000000 (Series D)
  • • InsideSales: $61000000 (Series D)
  • • InsideSales: $100000000 (Series C)
  • • Bitium: $6000000 (Series Unknown)
  • • Bitium: $7000000 (Series A)
  • • Upland Localytics: $35000000 (Series D)
  • • Upland Localytics: $16000000 (Series C)
  • • Upland Localytics: $6000000 (Series B)
  • • Vhoto: $750000 (Seed)
  • • Vhoto: $2000000 (Seed)
  • • Egnyte: $30000000 (Series D)
  • • Egnyte: $16000000 (Series C)
  • • Egnyte: $6000000 (Series A)
  • • Logentries: $10000000 (Series A)
  • • Logentries: $1000000 (Seed)
  • • Phytel: $14000000 (Series Unknown)
  • • Imprivata: $15000000 (Series C)
  • • Imprivata: $12000000 (Series B)
  • • Imprivata: $4000000 (Series A)
  • • Imprivata: $14000000 (Series A)
  • • Archivas: $12000000 (Series C)
  • • Archivas: $10000000 (Series B)
  • • Archivas: $6000000 (Series A)
  • • LogMeIn: $10000000 (Series B)
  • • Integrian: $13000000 (Series B)
  • • FIRE1: $120000000 (Series Unknown)
  • • Satellite Bio: $82000000 (Series A)
  • • Montis Biosciences: $9000000 (Seed)
  • • Tectonic Therapeutic: $130000000 (Post Ipo Equity)
  • • Tectonic Therapeutic: $80000000 (Series A)
  • • Ankyra: $45000000 (Series B)
  • • Invivyd: $340000000 (Series C)
  • • Invivyd: $80000000 (Series B)
  • • Invivyd: $50000000 (Series A)
  • • Iora Health: $130000000 (Series F)
  • • Iora Health: $100000000 (Series E)
  • • Iora Health: $75000000 (Series D)
  • • Iora Health: $28000000 (Series C)
  • • Iora Health: $14000000 (Series B)
  • • Arsanis: $46000000 (Series D)
  • • Arsanis: $20000000 (Series B)
  • • Arsanis: $10000000 (Series A)
  • • Alector: $30000000 (Series D)
  • • Alector: $32000000 (Series C)
  • • Alector: (Series A)
  • • Editas Medicine: $120000000 (Series B)
  • • Editas Medicine: $43000000 (Series A)
  • • PULMATRIX, INC.: $10000000 (Post Ipo Equity)
  • • PULMATRIX, INC.: $14000000 (Series B)
  • • PULMATRIX, INC.: $30000000 (Series B)
  • • PULMATRIX, INC.: $4000000 (Series A)
  • • Arsenal Medical: $16000000 (Series Unknown)
  • • Arsenal Medical: $10000000 (Series Unknown)
  • • Arsenal Medical: $13000000 (Series B)
  • • 480 Biomedical: $12000000 (Series C)
  • • 480 Biomedical: $15000000 (Series A)
  • • Pymetrics: $3000000 (Seed)
  • • WikiCell Designs: $10000000 (Series A)
  • • Adimab: $14000000 (Series F)
  • • Adimab: $8000000 (Series D)
  • • Adimab: $4000000 (Series C)
  • • Adimab: $3000000 (Series B)
  • • Adimab: $6000000 (Series A)
  • • Adimab: $6000000 (Series A)
  • • Trevena: $35000000 (Series B)
  • • Trevena: $24000000 (Series A)
  • • Acceleron Pharma: $10000000 (Series Unknown)
  • • Acceleron Pharma: $31000000 (Series C)
  • • Acceleron Pharma: $30000000 (Series B)
  • • MicroCHIPS: $17000000 (Series Unknown)
  • • Remon Medical Technologies: $10000000 (Series C)
  • • Remon Medical Technologies: $16000000 (Series C)
  • • Remon Medical Technologies: $10000000 (Series A)
  • • TRex Bio: $84000000 (Series B)
  • • TRex Bio: $26000000 (Series A)
  • • Sunbird Bio: $14000000 (Series Unknown)
  • • EpiBiologics: $73000000 (Series A)
  • • Auron Therapeutics: $48000000 (Series A)
  • • Matter Neuroscience: $26000000 (Seed)
  • • Freenome: $250000000 (Series Unknown)
  • • Freenome: $300000000 (Series D)
  • • Freenome: $270000000 (Series C)
  • • Freenome: $160000000 (Series B)
  • • Freenome: $7000000 (Series A)
  • • Freenome: $65000000 (Series A)
  • • Jnana Therapeutics: $110000000 (Series C)
  • • Jnana Therapeutics: $50000000 (Series A)
  • • Scholar Rock: $210000000 (Post Ipo Equity)
  • • Scholar Rock: $47000000 (Series C)
  • • Scholar Rock: $36000000 (Series B)
  • • Scholar Rock: $20000000 (Series A)
  • • Dewpoint Therapeutics: $150000000 (Series C)
  • • Dewpoint Therapeutics: $77000000 (Series B)
  • • Dewpoint Therapeutics: $60000000 (Series A)
  • • Kojin Therapeutics: $60000000 (Series A)
  • • Primmune Therapeutics: $27000000 (Series A)
  • • 1366 Technologies: $18000000 (Series E)
  • • 1366 Technologies: $15000000 (Series C)
  • • 1366 Technologies: $6000000 (Series B)
  • • 1366 Technologies: $20000000 (Series B)
  • • AgBiome: $65000000 (Series C)
  • • AgBiome: $35000000 (Series B)
  • • AgBiome: $18000000 (Series Unknown)
  • • AgBiome: $18000000 (Series A)
  • • Sofregen Medical: $6000000 (Series A)
  • • Olivo Laboratories LLC: (Seed)
  • • Selecta Biosciences: $38000000 (Series E)
  • • Selecta Biosciences: $20000000 (Private Equity)
  • • Selecta Biosciences: $15000000 (Series C)
  • • Selecta Biosciences: $15000000 (Series B)
  • • aTyr Pharma: $49000000 (Series D)
  • • aTyr Pharma: $23000000 (Series C)
  • • aTyr Pharma: $12000000 (Series C)
  • • aTyr Pharma: $11000000 (Series B)
  • • Promedior: $22000000 (Series D)
  • • Promedior: $14000000 (Series A)
  • • Fate Therapeutics: $36000000 (Series B)
  • • Fate Therapeutics: $12000000 (Series A)
  • • Sun Catalytix: $10000000 (Series B)
  • • Sun Catalytix: $1000000 (Seed)
  • • BIND Therapeutics: $12000000 (Series C)
  • • BIND Therapeutics: $16000000 (Series B)
  • • BIND Therapeutics: $3000000 (Series A)
  • • Pervasis Therapeutics: $17000000 (Series C)
  • • Pervasis Therapeutics: $10000000 (Series Unknown)
  • • Pervasis Therapeutics: $12000000 (Series B)
  • • Pervasis Therapeutics: $2000000 (Series A)
  • • Pervasis Therapeutics: $500000 (Seed)
  • • Avila Therapeutics: $30000000 (Series B)
  • • Athenix: $10000000 (Series D)
  • • Athenix: $13000000 (Series C)
  • • Athenix: $13000000 (Series B)
  • • Athenix: $8000000 (Series A)
  • • Tessa Therapeutics: $130000000 (Series A)
  • • EGenesis: $130000000 (Series C)
  • • Emergency Reporting: (Private Equity)
  • • August Bioservices: $65000000 (Series B)
  • • August Bioservices: $24000000 (Series A)
  • • Nomad Health: $110000000 (Series Unknown)
  • • Nomad Health: $63000000 (Series D)
  • • Nomad Health: $34000000 (Series C)
  • • Nomad Health: $12000000 (Series B)
  • • BlackThorn Therapeutics: $76000000 (Series B)
  • • KenSci: $22000000 (Series B)
  • • US HealthVest: $50000000 (Series B)
  • • US HealthVest: $36000000 (Series A)
  • • First Opinion: $6000000 (Series A)
  • • Suneva Medical: $15000000 (Debt Financing)
  • • Suneva Medical: $20000000 (Series B)
  • • Apnex Medical: $20000000 (Series C)
  • • Apnex Medical: $14000000 (Series B)
  • • Apnex Medical: $16000000 (Series A)
  • • BridgePoint Medical: $9000000 (Series C)
  • • BridgePoint Medical: $6000000 (Series Unknown)
  • • BridgePoint Medical: $10000000 (Series B)
  • • BridgePoint Medical: $1000000 (Series A)
  • • Respicardia: $27000000 (Series C)
  • • Respicardia: $21000000 (Series B)
  • • Free & Clear: $10000000 (Series Unknown)
  • • Transoma Medical: $5000000 (Series D)
  • • Transoma Medical: $13000000 (Series C)
  • • Transoma Medical: $13000000 (Series B)
  • • Transoma Medical: $12000000 (Series A)
  • • Ultreo: $18000000 (Series C)
  • • Ultreo: $11000000 (Series C)
  • • UltraShape Ltd. (Syneron Medical): $15000000 (Series Unknown)
  • • Archus Orthopedics: $35000000 (Series C)
  • • Archus Orthopedics: $18000000 (Series B)
  • • TransACT: (Private Equity)
  • • Iridium Technology: (Private Equity)
  • • NetRate Systems: (Series Unknown)
  • • Baxter Planning: $25000000 (Series Unknown)
  • • Cityworks: $15000000 (Series Unknown)
  • • Dealer Spike: (Series Unknown)
  • • Strata Health: (Series Unknown)
  • • Alimera Sciences: $5000000 (Series C)
  • • Alimera Sciences: $30000000 (Series C)
  • • Alimera Sciences: $32000000 (Series B)
  • • Alimera Sciences: $27000000 (Series A)
  • • e-Rewards: $60000000 (Private Equity)
  • • e-Rewards: $15000000 (Series Unknown)
  • • Cushcraft Corp.: (Series Unknown)
  • • SmartMail Services: $45000000 (Series C)
  • • Living Proof: $30000000 (Series C)
  • • Living Proof: $16000000 (Series B)
  • • Living Proof: $7000000 (Series A)
  • • EXOS: $23000000 (Series Unknown)
  • • EXOS: $5000000 (Series B)
  • • EXOS: (Series A)
  • • JibJab Bros Studios: $8000000 (Series C)
  • • JibJab Bros Studios: $3000000 (Series B)
  • • JibJab Bros Studios: $6000000 (Series A)

Polaris Partners

Boston Massachusetts, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Analytics • Cloud Services (& Infrastructure) • Future Of Work • Human Resources • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Mobile • Consumer • Pharmaceutical (& Medicine) • Diagnostics

Description

Polaris Venture Partners is a venture capital firm that invests in seed, early, later and expansion stage companies operating in the technology and healthcare sectors. The firm was founded in 1996 and is based in Boston, Massachusetts.

main investor picture
DigiTx Partners
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Califor..., United States
  • main investor picture
    David Kim
    Partner
  • main investor picture
    David J. Kim
  • main investor picture
    Miraj Sanghvi
    Principal
  • main investor picture
    Emre Karatas
    Analyst
Investor Picture
Previous Investments
  • • Eko (Monitoring Equipment): $20000000 (Later stage VC)
  • • N?osus: $16500000 (Later stage VC)
  • • Savonix, Inc.: $5100000 (Early stage VC)
  • • Juji, Inc.: (Seed Round)
  • • Sensoplex: (Seed Round)
  • • Ciba Health: $10000000 (Series A)
  • • Lifelink Systems: $10000000 (Series A)
  • • nQ Medical: $3000000 (Seed)

DigiTx Partners

San Francisco California - Blockchain - Human capital - San Francisco Bay Area, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Human Resources • Insurance (& InsurTech) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Investment Management • Life Science • Pharmaceutical (& Medicine) • Diagnostics

Description

DigiTx Partners is a venture capital firm founded in 2016 and is based in South San Francisco, California. The firm was launched as a joint venture by Astellas Pharma and MPM Capital. It invests in early-stage firms operating in the medicine and healthcare sectors.

main investor picture
Congruent Ventures
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Califor..., United States
  • main investor picture
    Joshua Posamentier
    Managing Partner
  • main investor picture
    Abe Yokell
    Managing Partner
  • main investor picture
    Christina O'Conor
    Partner
  • main investor picture
    Abraham Yokell
    Partner
Investor Picture
Previous Investments
  • • Flywheel Software: $12000000 (Series C)
  • • Flywheel Software: $14800000 (Series B)
  • • Flywheel Software: $7300000 (Venture Round)
  • • Omnidian, Inc.: $5100000 (Seed Round)
  • • Phase Genomics: $1000000 (Seed Round)
  • • Energetic Insurance, Inc.: $630000 (Other)
  • • Bellwether Coffee:
  • • Hopthru:
  • • Flywheel (Application Software): $760000 (Early Stage VC)
  • • Leap (Media and Information Services): (Angel)
  • • Meati Foods: $50000000 (Series B)
  • • Meati Foods: $25000000 (Series A)
  • • Leap: $12000000 (Series Unknown)
  • • AMP Robotics: $91000000 (Series C)
  • • AMP Robotics: $55000000 (Series B)
  • • AMP Robotics: $16000000 (Series A)
  • • AMP Robotics: (Seed)
  • • AMP: $91000000 (Series D)
  • • AMP: $91000000 (Series C)
  • • AMP: $55000000 (Series B)
  • • AMP: $16000000 (Series A)
  • • AMP: (Seed)
  • • Demex: $10000000 (Series A)
  • • Camus Energy: $10000000 (Series A)
  • • Camus Energy: $16000000 (Series A)
  • • Omnidian: $25000000 (Series Unknown)
  • • Omnidian: $33000000 (Series B)
  • • Omnidian: $15000000 (Series A)
  • • Omnidian: $5000000 (Seed)
  • • Pano: $17000000 (Series A)
  • • Evergrow: $7000000 (Seed)
  • • Evergrow: $7000000 (Seed)
  • • Qnovo: $24000000 (Series C)
  • • Qnovo: $9000000 (Series B)
  • • Qnovo: $7000000 (Series A)
  • • Qnovo: $1000000 (Seed)
  • • MilkRun: $6000000 (Series A)
  • • Thrilling: $9000000 (Series A)
  • • Amply Power: $13000000 (Series A)
  • • Amply Power: $2000000 (Seed)
  • • Amply Power: $1000000 (Seed)
  • • Blueprint Power: $4000000 (Series A)
  • • Renovate America: $90000000 (Private Equity)
  • • Renovate America: $50000000 (Private Equity)
  • • Renovate America: $6000000 (Series C)
  • • EcoFactor: $7000000 (Series C)
  • • EcoFactor: $10000000 (Series B)
  • • EcoFactor: $9000000 (Series A)
  • • EcoFactor: $4000000 (Series A)
  • • Flywheel: $12000000 (Series C)
  • • Flywheel: $15000000 (Series B)
  • • Flywheel: $7000000 (Series Unknown)
  • • Streetline: $10000000 (Series D)
  • • Streetline: $25000000 (Series C)
  • • Streetline: $15000000 (Series B)
  • • REPOWER by Solar Universe: $7000000 (Series B)
  • • Enphase Energy: $40000000 (Series Unknown)
  • • Enphase Energy: $23000000 (Series Unknown)
  • • Eka Systems: $19000000 (Series D)
  • • Eka Systems: $13000000 (Series C)
  • • Forterra: $75000000 (Series B)
  • • Dispatch Goods: $4000000 (Seed)
  • • Applied Carbon: $22000000 (Series A)
  • • Fervo Energy: $240000000 (Series D)
  • • Lydian: $12000000 (Seed)
  • • VEIR: $25000000 (Series A)
  • • VEIR: $11000000 (Series A)
  • • Robigo: $7000000 (Seed)
  • • Parallel Systems: $50000000 (Series A)
  • • Parallel Systems: $4000000 (Seed)
  • • Meati: $50000000 (Series B)
  • • Meati: $28000000 (Series A)
  • • Meati: $5000000 (Seed)
  • • QuantumScape: (Series Unknown)

Congruent Ventures

San Francisco California - San Francisco Bay Area, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • Cannabis • Autonomous vehicles (& Cars) • Food & Beverage • Impact • Robotics • DeepTech • FoodTech • Healthcare (& Wellness) • Investment Management • Life Science • Mobility • Online Social • Consumer • Pharmaceutical (& Medicine) • Oil & Gas (& Mining) • Industrials • 3D Printing • Diagnostics

Description

Congruent Ventures is a venture capital firm that invests in early stage sustainable technology companies. It is based in San Francisco, California and was founded in 2016.

main investor picture
Panakes Partners
Investing in BioTech • HealthTech (& Fitness...
 Milan, Italy
  • main investor picture
    Diana Saraceni
    Founder and Managing Partner
  • main investor picture
    Alessio Beverina
    Founder and Managing Partner
  • main investor picture
    Alessio Piuma
    Associate
  • main investor picture
    Barbara Castellano
    Principal
  • main investor picture
    Fabrizio Landi
    President, Founder and Managing Partner
  • main investor picture
    Giacomo Piccinini
    Analyst
  • main investor picture
    Michele Alloni
    Analyst
  • main investor picture
    Laura Brolis
    CFO
Investor Picture
Previous Investments
  • • Salvia BioElectronics: $24860000 (Later stage VC)
  • • SamanTree Medical: $9380000 (Early stage VC)
  • • Aileens Pharma: $3510000 (Early stage VC)

Panakes Partners

Milan, Italy

Contact this investors  
Investing In

BioTech • HealthTech (& Fitness) • Cannabis • Medical Devices (& Hospital Services) • Life Science • Pharmaceutical (& Medicine) • Diagnostics

Description

Panakes Partners is a venture Capital investor that invests in the health sector. The firm was founded in 2015 and is based in Milano, Italy.

main investor picture
Finch Capital
Investing in Software (Web Marketplace Saas..) &b...
 Indonesia, Netherlands
  • main investor picture
    Aman Ghei
    Partner
  • main investor picture
    Mike Brennan
    Principal
  • main investor picture
    Radboud Vlaar
    Managing Partner
  • main investor picture
    Dick Harryvan
    Partner
  • main investor picture
    Hans De Back
    Partner
  • main investor picture
    Jorn Gerrits
    CFO
  • main investor picture
    George Coehlo
    Investment Advisor
  • main investor picture
    Eugénie Colonna d'Istria
    Associate
Investor Picture
Previous Investments
  • • Twisto: $19520000 (Later stage VC)
  • • Knip: $15700000 (Later stage VC)
  • • Squirro: $10000000 (Later stage VC)
  • • Ikbenfrits.nl: $2000000 (Early stage VC)
  • • Ayopop: (Early stage VC)
  • • Intelliment Security: (Seed Round)
  • • Cermati: (Early stage VC)
  • • Digital Insurance Group 0:
  • • Halofina:
  • • big xyt: $11000000 (Series Unknown)
  • • eflow: $9000000 (Series A)
  • • symmetrical.ai: $19000000 (Series A)
  • • symmetrical.ai: $6000000 (Seed)
  • • symmetrical.ai: $2000000 (Pre Seed)
  • • Lantum: $15000000 (Series Unknown)
  • • Lavanda: $7000000 (Series B)
  • • NomuPay: $54000000 (Series A)
  • • Fourthline: $55000000 (Series B)
  • • in3: $85000000 (Series B)
  • • in3: $11000000 (Series A)
  • • Goodlord: $35000000 (Series B)
  • • Goodlord: $13000000 (Series B)
  • • Goodlord: $9000000 (Series B)
  • • Fixico: $14000000 (Series A)
  • • Fixico: $6000000 (Seed)
  • • Fixico: $2000000 (Pre Seed)
  • • Better.co.uk: $10000000 (Series Unknown)
  • • Better.co.uk: $18000000 (Series B)
  • • Better.co.uk: $6000000 (Series A)
  • • Digital Insurance Group: $17000000 (Series A)
  • • Digital Insurance Group: (Seed)
  • • Brickblock: $3000000 (Series A)
  • • Jump: (Pre Seed)
  • • Legalbase: (Seed)
  • • BUX: $7000000 (Series B)
  • • BUX: (Seed)
  • • Salviol Global Analytics: $7000000 (Series A)
  • • Komparu: (Series A)
  • • Moni Technologies: $120000 (Seed)
  • • Zopa: (Series D)
  • • Webio: $820000 (Series Unknown)
  • • Webio: $4000000 (Series A)
  • • Webio: $610000 (Seed)
  • • AccountsIQ: $7000000 (Series Unknown)
  • • AYLIEN: $6000000 (Series A)
  • • SMEO: $5000000 (Series Unknown)
  • • Pintek: $7000000 (Series A)
  • • Pintek: (Series Unknown)
  • • Pintek: (Seed)
  • • Pintek: $260000 (Seed)
  • • TADA: (Series B)
  • • TADA: (Series B)
  • • Frits.com: $2000000 (Seed)

Finch Capital

Indonesia, Netherlands

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • PropTech • IT (& TMT) • Education • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • Sales (& Marketing) • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Blockchain (& Cryptos) • Web Security (& Privacy) • Autonomous vehicles (& Cars) • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Payments • Real Estate (& Construction) • DeepTech • Healthcare (& Wellness) • Investment Management • Life Science • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics

Description

Finch Capital (formerly Orange Growth Capital) is a venture capital firm investing in early stage companies. We are thematic investors focusing on technology-enabled innovation bringing about the transformation of the financial services sector. Finch Capital has three offices in Amsterdam, London and Singapore, out of which it is supporting bold entrepreneurs. We have made 19 investments in leading financial technology businesses across the Netherlands, UK, Germany, Switzerland, Spain and Indonesia. Finch Capital is now investing its second fund with a geographic focus on Europe and selectively on South East Asia.

main investor picture
Upfront Ventures
Investing in Software (Web Marketplace Saas..) &b...
 California , Paris , ..., United States
  • main investor picture
    Mark Suster
    General Partner
  • main investor picture
    Aditi Maliwal
    Partner
  • main investor picture
    Nick Kim
    General Partner
  • main investor picture
    Kevin Zhang
    Partner
  • main investor picture
    Kobie Fuller
    General Partner
  • main investor picture
    Yves Sisteron
    Advisor
  • main investor picture
    Alice Cheng
    Associate
  • main investor picture
    Dana Kibler
    Advisor
  • main investor picture
    Stuart Lander
    COO
  • main investor picture
    Josh Mittler
    Advisor
  • main investor picture
    Seksom Suriyapa
    General Partner
  • main investor picture
    Kesar Varma
    Investor
  • main investor picture
    AJ Herrera
    Investor
  • main investor picture
    Jacques Sisteron
    Investor
  • main investor picture
    Katherine Zhang
    Investor
  • main investor picture
    Christina Fattore
    Associate
Investor Picture
Previous Investments
  • • ALL DAY MEDIA: $2300000 (Seed Round)
  • • uBeam: $10000000 (Series A)
  • • ChowNow: $1000000 (Series A)
  • • Rally Rd.: $7000000 (Series A)
  • • GOAT Group: $60000000 (Series C)
  • • HopSkipDrive: $7400000 (Series A)
  • • HopSkipDrive: $10200000 (Series A)
  • • Happy Returns: $4000000 (Series A)
  • • Deliv: $28000000 (Series B)
  • • Deliv: $4500000 (Series A)
  • • Deliv: $6900000 (Series A)
  • • DRAFT: $3500000 (Series A)
  • • Retention Science: $7000000 (Series A)
  • • thredUP: $25000000 (Series D)
  • • Chromatik: $2000000 (Seed Round)
  • • DroneBase: $20000000 (Venture Round)
  • • DroneBase: $12500000 (Series C)
  • • DroneBase: $7500000 (Series C)
  • • DroneBase: $12000000 (Series B)
  • • DroneBase: $6800000 (Series A)
  • • Pinwheel: $20000000 (Series A)
  • • Pinwheel: $7000000 (Seed Round)
  • • Rally: $30000000 (Series B)
  • • Rally: $7000000 (Series A)
  • • Loupe: $3000000 (Seed Round)
  • • Landline: $3900000 (Seed Round)
  • • inVia Robotics: $20000000 (Series B)
  • • Rival: $25000000 (Series B)
  • • Rubica: $9000000 (Series A)
  • • Pragma: $12000000 (Series A)
  • • Pragma: $4200000 (Seed Round)
  • • Solve HQ: $20000000 (Series Unknown)
  • • Stage: $5000000 (Seed)
  • • Dayslice: $6000000 (Seed)
  • • Endgame: $30000000 (Series B)
  • • Endgame: $5000000 (Seed)
  • • Endgame: $5000000 (Seed)
  • • Eterneva: $10000000 (Series A)
  • • Britive: $10000000 (Series A)
  • • Britive: $5000000 (Seed)
  • • Territory Foods: $22000000 (Series B)
  • • Territory Foods: $4000000 (Series A)
  • • Territory Foods: $4000000 (Series A)
  • • Territory Foods: $7000000 (Series A)
  • • Territory Foods: $5000000 (Seed)
  • • Stem Disintermedia: $10000000 (Series Unknown)
  • • Stem Disintermedia: $8000000 (Series A)
  • • Stem Disintermedia: $5000000 (Seed)
  • • Fleetsmith: $30000000 (Series B)
  • • Fleetsmith: $8000000 (Series A)
  • • Skylar: $8000000 (Series A)
  • • Skylar: $3000000 (Seed)
  • • The Wing: $75000000 (Series C)
  • • Qordoba: $12000000 (Series B)
  • • Qordoba: $5000000 (Series A)
  • • Parachute Home: $30000000 (Series C)
  • • Parachute Home: $4000000 (Seed)
  • • Parachute Home: $800000 (Seed)
  • • Strive: $4000000 (Seed)
  • • Waldo Photos: $5000000 (Seed)
  • • LeoLabs: $13000000 (Series A)
  • • AirMap: $26000000 (Series B)
  • • Path: $18000000 (Series A)
  • • Path: $5000000 (Seed)
  • • Bionaut Labs: $43000000 (Series B)
  • • Bionaut Labs: $20000000 (Series A)
  • • CertifyOS: $15000000 (Series A)
  • • CertifyOS: $5000000 (Seed)
  • • Tellie: $10000000 (Series A)
  • • Omni Creator Products: $4000000 (Seed)
  • • Pragma Platform: $22000000 (Series B)
  • • Pragma Platform: $12000000 (Series A)
  • • Pragma Platform: $4000000 (Seed)
  • • Rula: $18000000 (Series A)
  • • Rula: $5000000 (Seed)
  • • Stray Bombay: $5000000 (Seed)
  • • Seriously: $18000000 (Series A)
  • • Seriously: $5000000 (Seed)
  • • Seriously: $3000000 (Seed)
  • • Seriously: $2000000 (Seed)
  • • Grove: $2000000 (Seed)
  • • OurSky: $10000000 (Seed)
  • • Jiko: $29000000 (Series C)
  • • Jiko: $40000000 (Series B)
  • • Jiko: $40000000 (Series A)
  • • Jiko: $8000000 (Seed)
  • • Reveleer: $65000000 (Series Unknown)
  • • Reveleer: $6000000 (Series C)
  • • Reveleer: $3000000 (Series B)
  • • Reveleer: $3000000 (Series A)
  • • Reveleer: $3000000 (Series A)
  • • Reveleer: $1000000 (Series A)
  • • Reveleer: $3000000 (Series A)
  • • Apeel Sciences: $250000000 (Series D)
  • • Apeel Sciences: $70000000 (Series C)
  • • Apeel Sciences: $33000000 (Series B)
  • • Apeel Sciences: $6000000 (Series A)
  • • NuORDER: $15000000 (Series C)
  • • NuORDER: $8000000 (Series B)
  • • NuORDER: $3000000 (Series Unknown)
  • • NuORDER: $8000000 (Series A)
  • • NuORDER: $4000000 (Seed)
  • • Teforia Company: $12000000 (Series A)
  • • Teforia Company: $5000000 (Seed)
  • • Nima: $9000000 (Series A)
  • • Nima: $4000000 (Seed)
  • • SOOT: $7000000 (Seed)
  • • Cordial: $50000000 (Series C)
  • • Cordial: $15000000 (Series B)
  • • Cordial: $7000000 (Series A)
  • • Hairtelligence: $5000000 (Seed)
  • • Martie: $3000000 (Seed)
  • • Bevy: $40000000 (Series C)
  • • Bevy: $15000000 (Series B)
  • • Bevy: $6000000 (Series A)
  • • SureSale: $7000000 (Series A)
  • • MetaCX: $14000000 (Series Unknown)
  • • UserTesting: $46000000 (Series C)
  • • Open Raven: $20000000 (Series B)
  • • Arcade: $14000000 (Series A)
  • • Arcade: $3000000 (Seed)
  • • Renew: $8000000 (Seed)
  • • Finary: $3000000 (Seed)
  • • Clair: $5000000 (Seed)
  • • PowerToFly: $7000000 (Series A)
  • • Modern Animal: $46000000 (Series D)
  • • Safe: $1000000 (Pre Seed)
  • • Heroic Story: $6000000 (Seed)
  • • Queer Spaces: $1000000 (Convertible Note)
  • • Remento: $3000000 (Seed)
  • • Invoca: $83000000 (Series F)
  • • Invoca: $56000000 (Series E)
  • • Invoca: $30000000 (Series D)
  • • Invoca: $22000000 (Series C)
  • • Invoca: $3000000 (Series Unknown)
  • • Invoca: $4000000 (Series B)
  • • Invoca: $4000000 (Series A)
  • • Secfense: $2000000 (Seed)
  • • VADE: $4000000 (Seed)
  • • Density: $130000000 (Series D)
  • • Density: $51000000 (Series C)
  • • Density: $4000000 (Series A)
  • • GumGum: $75000000 (Series E)
  • • GumGum: $22000000 (Series D)
  • • GumGum: $26000000 (Series C)
  • • GumGum: $7000000 (Series B)
  • • GumGum: $3000000 (Series A)
  • • Nanit: $25000000 (Series C)
  • • Nanit: $21000000 (Series B)
  • • Nanit: $14000000 (Series B)
  • • Nanit: $8000000 (Series A)
  • • Nanit: $7000000 (Seed)
  • • InfoSum: $15000000 (Series A)
  • • InfoSum: $5000000 (Seed)
  • • InfoSum: $3000000 (Seed)
  • • MakeSpace: $45000000 (Series E)
  • • MakeSpace: $30000000 (Corporate Round)
  • • MakeSpace: $30000000 (Series C)
  • • MakeSpace: $18000000 (Series B)
  • • MakeSpace: $8000000 (Series A)
  • • MakeSpace: $2000000 (Seed)
  • • SOLVE: $20000000 (Series Unknown)
  • • Aircam: $7000000 (Seed)
  • • Tact.ai: $27000000 (Series C)
  • • Tact.ai: $15000000 (Series B)
  • • SonicEnergy™: $20000000 (Series B)
  • • SonicEnergy™: $10000000 (Series A)
  • • Skurt: (Convertible Note)
  • • Skurt: $10000000 (Series A)
  • • Skurt: $1000000 (Seed)
  • • MyTime: $6000000 (Series C)
  • • MyTime: $11000000 (Series B)
  • • MyTime: $3000000 (Series A)
  • • Osmo: $18000000 (Series B)
  • • Osmo: $12000000 (Series A)
  • • Osmo: $3000000 (Seed)
  • • ALL DAY: $2000000 (Seed)
  • • Projector App: $4000000 (Seed)
  • • Ferris: $2000000 (Seed)
  • • Wheel: $2000000 (Seed)
  • • Vidme: $3000000 (Seed)
  • • Epoxy: $7000000 (Series A)
  • • Epoxy: $2000000 (Seed)
  • • REDEF: $2000000 (Seed)
  • • Adly: $2000000 (Series Unknown)
  • • Adly: $5000000 (Series B)
  • • Adly: $500000 (Seed)
  • • Neverware: $1000000 (Seed)
  • • Maker Studios: $36000000 (Series C)
  • • Maker Studios: $2000000 (Series B)
  • • Maker Studios: $2000000 (Series A)
  • • Gravity: $11000000 (Series B)
  • • ecomom: $4000000 (Series A)
  • • ecomom: $1000000 (Angel)
  • • awe.sm: $4000000 (Series Unknown)
  • • awe.sm: $1000000 (Seed)
  • • Burstly: $6000000 (Series Unknown)
  • • Pose.com: $3000000 (Series A)
  • • Pose.com: $2000000 (Series Unknown)
  • • Treehouse: $600000 (Seed)
  • • GameSalad: $6000000 (Series A)
  • • GameSalad: $1000000 (Series A)

Upfront Ventures

California - Paris - Santa Monica, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • Entertainment (& Sports) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Blockchain (& Cryptos) • Web Security (& Privacy) • Gaming (& eSports) • Advertising • Analytics • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Human Resources • Impact • Insurance (& InsurTech) • Local commerce • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Payments • Aerospace (& Defense) • SaaS • DeepTech • Healthcare (& Wellness) • Life Science • Mobility • Nanotechnology • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics

Description

Most Interested In

Interactive media (gaming, VR/AR, livestreaming, etc.), healthcare, AI, computer vision, IoT, natural sciences

main investor picture
Global Health Impact Fund
Investing in BioTech • HealthTech (& Fitness...
 San Francisco Califor..., United States
Investor Picture
Previous Investments
  • • HanGenix Solutions: $2000000 (Seed Round)
  • • Raydiant Oximetry: $8000000 (Series A)
  • • Wealth Advisor Ratings: $25000 (PreSeed)

Global Health Impact Fund

San Francisco California - San Francisco Bay Area, United States

Contact this investors  
Investing In

BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics

Description

Founded by clinicians in 2018, Global Health Impact Fund is a venture capital firm run by physicians with extensive financial and entrepreneurial experience. GHIF makes investments in seed-stage, early-stage, and later-stage companies throughout the healthcare vertical. The first fund is focused on digital health, telemedicine, and medical devices. GHIF investments are strategic in that the fund is able to leverage its expertise, along with that of its LP network with many physicians, to support portfolio companies and optimize their chances for successful exits.

main investor picture
iSelect Fund
Investing in Software (Web Marketplace Saas..) &b...
 St Louis Missouri , B..., United States
  • main investor picture
    Carter Williams
    GP/MD
  • main investor picture
    Mark McCall
    Managing Director
  • main investor picture
    David Yocom
    Associate
  • main investor picture
    Craig Herron
    Managing Director
  • main investor picture
    Michael Kime
    Vice President
  • main investor picture
    Tom Bunn
    Associate
Investor Picture
Previous Investments
  • • Cofactor Genomics: $18000000 (Early stage VC)
  • • Agrible: $9700000 (Later stage VC)
  • • Holganix: $3000000 (Later stage VC)
  • • Epharmix: $2300000 (Seed Round)
  • • PopBookings: $1000000 (Later stage VC)
  • • FairWords: $850000 (Seed Round)
  • • Kultevat, Inc.: (Later stage VC)
  • • Bond Pet Foods: $18000000 (Series A)
  • • Autonomous Pivot: $250000 (Seed Round)
  • • Flywheel.io: $15000000 (Series B)
  • • Geltor: $18000000 (Series A)
  • • Flywheel Software: $7300000 (Venture Round)
  • • ImmunoPhotonics: $21000000 (Series B)
  • • ImmunoPhotonics: $600000 (Series A)
  • • ImmunoPhotonics: $2000000 (Series A)
  • • Artemis: $8000000 (Series A)
  • • Artemis: $2000000 (Corporate Round)
  • • Brightseed Bio: $12000000 (Series A Round)
  • • Euclises Pharmaceuticals: $1000000 (Series Unknown)
  • • Euclises Pharmaceuticals: $2000000 (Series Unknown)
  • • StreamLink Software: $10000000 (Series Unknown)
  • • Open Studio Network: (Seed)
  • • Mentor Spaces: $1000000 (Seed)
  • • Antegrin Therapeutics: $800000 (Seed)
  • • Bractlet: $750000 (Seed)
  • • Ward Alternative Energy: (Series Unknown)
  • • BenchmarkONE: (Series Unknown)
  • • Kultevat: (Series Unknown)
  • • Gremlin Social: $500000 (Seed)
  • • Time To Cater: (Seed)
  • • Time To Cater: $100000 (Angel)
  • • CrazyForEducation: (Seed)
  • • adFreeq: (Seed)
  • • Tansna Therapeutics: $850000 (Seed)
  • • Tansna Therapeutics: (Angel)
  • • Growers Edge: (Series A)
  • • Bonumose: (A)
  • • AgriWebb: (Series A)
  • • Earth Optics: (Series A)
  • • Harp Bio: (Series A)
  • • PreventScripts: $2000000 (Series Unknown)
  • • Benson Hill: $25000000 (Series B)
  • • Molecular Assemblies: $26000000 (Series B)
  • • Molecular Assemblies: $12000000 (Series A)
  • • Molecular Assemblies: $12000000 (Series A)

iSelect Fund

St Louis Missouri - Boston Massachusetts - Michigan - St. Louis Missouri - Saint Louis Missouri - St . Louis, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • AgroTech • Businesses Solutions • Energy • Cosmetics (& Fashion) • Entertainment (& Sports) • IoT (& Wearables) • CleanTech • HealthTech (& Fitness) • Food & Beverage • Medical Devices (& Hospital Services) • SaaS • FoodTech • Healthcare (& Wellness) • Life Science • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics • Productivity

Description

Most Interested In

We invest in 3 verticals: 1) Agtech with an emphasis on soil health, 2) Food is Health and 3) Health / Wellness with an emphasis on chronic / metabolic disease with a bias towards early detection, intervention or prevention. We will also look at platform or enabling technologies for healthcare / life sciences.

Not Interested In

Consumer brands, small molecule therapeutics, or any solutions that are not targeted at chronic or metabolic disease.

Join the community!
Connect with investors & startup founders

Overview of the Diagnostics Industry

Overview of the Diagnostics Industry

The Diagnostics industry involves the development and provision of medical tests and tools used to detect and diagnose diseases and health conditions. This industry includes laboratory testing, imaging diagnostics, molecular diagnostics, and point-of-care testing. The global diagnostics market was valued at approximately $117 billion in 2020 and is projected to reach $207 billion by 2027, growing at a CAGR of 7.5%.

Growth Drivers

The growth of this industry is driven by advancements in diagnostic technology, increasing prevalence of chronic diseases, and the demand for early and accurate disease detection. These factors contribute to the expansion and innovation within the diagnostics sector.

Impact on Society

The Diagnostics industry has a significant impact on society by improving patient outcomes, enhancing the accuracy of medical diagnoses, and supporting public health efforts. Laboratory testing, imaging diagnostics, molecular diagnostics, and point-of-care testing provide essential information for diagnosing and monitoring various health conditions.

Types of Diagnostics

Laboratory testing, such as blood tests and tissue biopsies, provides essential information for diagnosing and monitoring health conditions. Imaging diagnostics, including MRI, CT scans, and X-rays, enable non-invasive visualization of the body’s internal structures. Molecular diagnostics, such as PCR and next-generation sequencing, offer precise identification of genetic mutations and infections. Point-of-care testing allows for quick diagnostics at the patient's bedside or in remote settings, improving access to care.

Response to COVID-19

The COVID-19 pandemic has underscored the critical importance of diagnostics, as widespread testing has been essential for controlling the spread of the virus and guiding public health responses. This has highlighted the industry's role in addressing global health crises.

Challenges

However, the industry faces challenges related to regulatory approval, data integration, and the need for cost-effective and accessible testing solutions. Addressing these challenges is crucial for the continued growth and innovation in the diagnostics sector.

Future Outlook

Despite these challenges, the potential benefits of diagnostics innovations are immense, and continued investment and innovation in this sector are essential for driving growth. As technology continues to advance, the Diagnostics industry will play a crucial role in shaping the future of healthcare.

Technological Advancements

The integration of artificial intelligence, machine learning, and advanced data analytics in diagnostics will further enhance the accuracy and efficiency of medical testing. These advancements will enable earlier and more personalized interventions, improving patient outcomes.

Conclusion

The future of the diagnostics industry will be defined by its ability to deliver high-quality, accessible, and cost-effective diagnostic solutions. Continued investment in this sector is essential for addressing the diverse healthcare needs of populations worldwide, supporting precision medicine, and enhancing disease detection.

How to connect with VC firms in the Diagnostics Industry?

Target Key VC Firms

To connect with VCs in the Diagnostics sector, target firms such as Sequoia Capital, Andreessen Horowitz, and OrbiMed. Research their investment portfolios to understand their focus areas and tailor your approach accordingly to align with their investment criteria.

Networking Opportunities

Networking through industry conferences, diagnostics summits, and medical forums can provide opportunities to meet VC partners. These events are essential for making connections, learning about industry trends, and gaining visibility in the diagnostics field.

Effective Pitching Strategies

When pitching, focus on demonstrating the market potential, technological innovation, and scalability of your diagnostics solution. Be prepared to discuss your business model, customer acquisition strategies, and revenue projections in detail to highlight the viability and growth prospects of your venture.

Participating in Demo Days

Participating in demo days hosted by medical tech accelerators or incubators can help you showcase your product to a broader audience of VCs. These platforms offer valuable exposure and feedback from potential investors.

Crafting a Compelling Story

Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors who are looking for high-growth potential startups. Emphasize the unique advantages and transformative potential of your technology.

Comprehensive Pitch Deck

Following up with a comprehensive pitch deck that includes market analysis, go-to-market strategy, and potential exit opportunities can further strengthen your case. This demonstrates a well-thought-out plan and clear pathway to success.

Highlighting Strategic Partnerships

Highlighting any strategic partnerships or collaborations with major healthcare providers or research institutions can add weight to your pitch. These alliances indicate validation and potential for enhanced market reach and impact.

Presenting a Strong Team

Ensuring that you present a well-rounded team with expertise in both diagnostics technology and business development will appeal to VCs looking for capable execution of your vision. A diverse and skilled team is crucial for driving your mission forward and achieving milestones.

Most active VC firms in the Diagnostics industry?

Target Firms

To connect with VCs in the Diagnostics sector, target firms such as Sequoia Capital, Andreessen Horowitz, and OrbiMed. These firms have a strong track record of investing in successful diagnostics startups.

Sequoia Capital

Sequoia Capital, known for backing companies like Guardant Health and 23andMe, focuses on high-growth potential and market disruption. Their investments are aimed at startups with innovative diagnostics solutions.

Andreessen Horowitz

Andreessen Horowitz, with investments in companies like Freenome and Color Genomics, looks for diagnostics solutions that can scale globally. They prioritize startups offering breakthrough technologies and significant market potential.

OrbiMed

OrbiMed, a leading healthcare investment firm, seeks out startups with strong scientific foundations and significant market potential in medical diagnostics. Their focus is on innovation and scalability.

Research and Connection

To connect with these VCs, research their investment portfolios and identify partners who have shown interest in your industry. This targeted approach will help you find the right VCs for your diagnostics startup.

Attending Industry Events

Attend industry conferences, diagnostics summits, and healthcare forums where these VCs are likely to be present. These events offer valuable networking opportunities and exposure for your startup.

Participating in Demo Days

Participating in demo days hosted by diagnostics tech accelerators or incubators can also provide exposure. Showcasing your startup at these events can attract the interest of VCs.

Pitching to VCs

When pitching to VCs, emphasize your startup’s market opportunity, technological innovation, and scalability. Highlight how your solutions address significant challenges in the diagnostics sector.

Crafting a Compelling Story

Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors. Focus on the unique value and advancements your technology offers.

Comprehensive Pitch Deck

Follow up with a comprehensive pitch deck that includes market analysis, competitive landscape, and potential exit opportunities. This detailed presentation will help VCs understand your startup’s prospects.

Strategic Partnerships

Highlighting any strategic partnerships or collaborations with major healthcare providers or research institutions can also add weight to your pitch. These partnerships validate your technology and enhance credibility.

Presenting a Strong Team

Ensuring that you present a well-rounded team with expertise in both diagnostics technology and business development will appeal to VCs looking for capable execution of your vision. A strong team is crucial for successful implementation and growth.

Comprehensive Guides to Raising Funds Online

By clicking on "Create Account" you accept our terms of service

Already have an account?
Login
Mike testimonial

Michael Colin - Founder of The MVMT



"We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

Taylor Testimonial

Taylor Matter - Founder & CEO, Hurdle Apparel



"Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who invested $200,000 in our brand."

founder clement

Clément Perrot - Co-Founder & CEO of Prynt



"Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


Create An Account
Copyright © 2026 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 days